Concepts (137)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pseudohypoparathyroidism | 4 | 2024 | 87 | 2.080 |
Why?
|
Chromogranins | 4 | 2024 | 160 | 1.280 |
Why?
|
GTP-Binding Protein alpha Subunits, Gs | 4 | 2024 | 194 | 1.220 |
Why?
|
Reflex, Abnormal | 1 | 2018 | 83 | 0.610 |
Why?
|
ACTH-Secreting Pituitary Adenoma | 1 | 2019 | 63 | 0.610 |
Why?
|
Genomic Imprinting | 3 | 2024 | 324 | 0.560 |
Why?
|
Adrenalectomy | 1 | 2019 | 348 | 0.550 |
Why?
|
Pituitary ACTH Hypersecretion | 1 | 2019 | 179 | 0.530 |
Why?
|
Adrenal Glands | 1 | 2019 | 557 | 0.530 |
Why?
|
Hypothyroidism | 1 | 2018 | 669 | 0.430 |
Why?
|
Activating Transcription Factor 4 | 1 | 2013 | 86 | 0.420 |
Why?
|
Gitelman Syndrome | 1 | 2011 | 4 | 0.390 |
Why?
|
Cholesterol Ester Transfer Proteins | 1 | 2011 | 113 | 0.360 |
Why?
|
Chromosomes, Human, Pair 16 | 1 | 2011 | 344 | 0.340 |
Why?
|
Diabetic Ketoacidosis | 2 | 2011 | 255 | 0.340 |
Why?
|
Glutamate Decarboxylase | 1 | 2010 | 239 | 0.320 |
Why?
|
Macrophages | 3 | 2021 | 5796 | 0.260 |
Why?
|
Stress, Physiological | 1 | 2013 | 1410 | 0.260 |
Why?
|
DNA Methylation | 3 | 2024 | 4421 | 0.230 |
Why?
|
Interleukin-6 | 2 | 2016 | 3230 | 0.230 |
Why?
|
Acetazolamide | 1 | 2023 | 96 | 0.220 |
Why?
|
GTP-Binding Protein alpha Subunits, Gq-G11 | 1 | 2024 | 148 | 0.210 |
Why?
|
Acidosis | 2 | 2019 | 271 | 0.210 |
Why?
|
Phytosterols | 1 | 2022 | 55 | 0.200 |
Why?
|
Diabetes Complications | 2 | 2019 | 1322 | 0.200 |
Why?
|
Diabetes Mellitus | 4 | 2022 | 5891 | 0.190 |
Why?
|
Frameshift Mutation | 1 | 2023 | 393 | 0.190 |
Why?
|
Lipid Metabolism, Inborn Errors | 1 | 2022 | 123 | 0.190 |
Why?
|
Self Administration | 1 | 2022 | 388 | 0.190 |
Why?
|
Toll-Like Receptor 4 | 2 | 2016 | 587 | 0.190 |
Why?
|
Hypercalcemia | 1 | 2024 | 423 | 0.180 |
Why?
|
Autoantibodies | 1 | 2010 | 2126 | 0.180 |
Why?
|
Influenza, Human | 1 | 2011 | 1539 | 0.170 |
Why?
|
Twins, Monozygotic | 1 | 2022 | 472 | 0.170 |
Why?
|
Diseases in Twins | 1 | 2022 | 447 | 0.170 |
Why?
|
Klinefelter Syndrome | 1 | 2019 | 48 | 0.160 |
Why?
|
Seizures | 1 | 2011 | 3000 | 0.150 |
Why?
|
Fibroblast Growth Factors | 1 | 2024 | 873 | 0.150 |
Why?
|
Intestinal Diseases | 1 | 2022 | 505 | 0.150 |
Why?
|
Mammals | 1 | 2023 | 1136 | 0.140 |
Why?
|
Serine | 1 | 2021 | 831 | 0.140 |
Why?
|
Mice, Knockout | 3 | 2024 | 14481 | 0.130 |
Why?
|
Hypercholesterolemia | 1 | 2022 | 1142 | 0.120 |
Why?
|
Cytokines | 3 | 2021 | 7445 | 0.120 |
Why?
|
Mitochondrial Diseases | 1 | 2019 | 344 | 0.120 |
Why?
|
Thyrotropin | 1 | 2018 | 834 | 0.120 |
Why?
|
eIF-2 Kinase | 1 | 2013 | 147 | 0.100 |
Why?
|
Alleles | 1 | 2024 | 6892 | 0.100 |
Why?
|
Sphenoid Sinus | 1 | 2013 | 101 | 0.100 |
Why?
|
Signal Transduction | 2 | 2024 | 23631 | 0.100 |
Why?
|
Diabetes Mellitus, Type 2 | 5 | 2022 | 12241 | 0.100 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2016 | 697 | 0.100 |
Why?
|
Receptors, Drug | 1 | 2011 | 157 | 0.090 |
Why?
|
Haploinsufficiency | 1 | 2013 | 336 | 0.090 |
Why?
|
Benzoates | 1 | 2012 | 213 | 0.090 |
Why?
|
Interleukin-17 | 1 | 2016 | 923 | 0.090 |
Why?
|
Acromegaly | 1 | 2013 | 316 | 0.090 |
Why?
|
Guillain-Barre Syndrome | 1 | 2011 | 127 | 0.090 |
Why?
|
Pedigree | 2 | 2022 | 4544 | 0.080 |
Why?
|
Angiotensin II Type 1 Receptor Blockers | 1 | 2012 | 429 | 0.080 |
Why?
|
Consanguinity | 1 | 2011 | 460 | 0.080 |
Why?
|
Asymptomatic Diseases | 1 | 2012 | 589 | 0.080 |
Why?
|
Symporters | 1 | 2011 | 363 | 0.080 |
Why?
|
NF-kappa B | 2 | 2016 | 2489 | 0.080 |
Why?
|
Seroepidemiologic Studies | 1 | 2010 | 405 | 0.080 |
Why?
|
Influenza A virus | 1 | 2011 | 460 | 0.070 |
Why?
|
Dietary Sucrose | 1 | 2010 | 243 | 0.070 |
Why?
|
Mitochondria | 1 | 2021 | 3675 | 0.070 |
Why?
|
Diabetic Angiopathies | 1 | 2012 | 806 | 0.070 |
Why?
|
Inflammation Mediators | 1 | 2016 | 1890 | 0.070 |
Why?
|
Benzimidazoles | 1 | 2012 | 864 | 0.070 |
Why?
|
Mutation | 1 | 2011 | 30228 | 0.070 |
Why?
|
Myocardial Perfusion Imaging | 1 | 2012 | 672 | 0.070 |
Why?
|
Homozygote | 1 | 2011 | 1779 | 0.070 |
Why?
|
Blood Glucose | 3 | 2022 | 6430 | 0.070 |
Why?
|
Weight Gain | 1 | 2016 | 2356 | 0.060 |
Why?
|
Fatty Acids | 1 | 2013 | 1815 | 0.060 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2013 | 1943 | 0.060 |
Why?
|
Humans | 17 | 2024 | 768393 | 0.060 |
Why?
|
Exercise Test | 1 | 2012 | 2186 | 0.060 |
Why?
|
Disease Models, Animal | 1 | 2024 | 18362 | 0.060 |
Why?
|
Insulin | 3 | 2022 | 6607 | 0.060 |
Why?
|
Beverages | 1 | 2010 | 819 | 0.060 |
Why?
|
Hypoglycemic Agents | 2 | 2022 | 3108 | 0.060 |
Why?
|
Mass Screening | 1 | 2019 | 5451 | 0.050 |
Why?
|
Hypophosphatemia | 1 | 2024 | 93 | 0.050 |
Why?
|
Middle Aged | 8 | 2019 | 223491 | 0.050 |
Why?
|
Promoter Regions, Genetic | 1 | 2013 | 5801 | 0.050 |
Why?
|
Animals | 5 | 2024 | 169337 | 0.050 |
Why?
|
Neurosurgical Procedures | 1 | 2013 | 2097 | 0.050 |
Why?
|
Insulin Resistance | 1 | 2013 | 3981 | 0.040 |
Why?
|
Acute Disease | 1 | 2010 | 7242 | 0.040 |
Why?
|
Female | 11 | 2024 | 397089 | 0.040 |
Why?
|
Coronary Disease | 1 | 2012 | 5924 | 0.040 |
Why?
|
Interleukin-1beta | 1 | 2024 | 1020 | 0.040 |
Why?
|
Lipoproteins | 1 | 2022 | 880 | 0.040 |
Why?
|
Male | 8 | 2024 | 364902 | 0.040 |
Why?
|
Parathyroid Hormone | 1 | 2024 | 1804 | 0.040 |
Why?
|
Follicle Stimulating Hormone | 1 | 2019 | 726 | 0.030 |
Why?
|
Luteinizing Hormone | 1 | 2019 | 821 | 0.030 |
Why?
|
Mice | 3 | 2024 | 82017 | 0.030 |
Why?
|
Oxygen Consumption | 1 | 2021 | 1882 | 0.030 |
Why?
|
Inflammation | 1 | 2013 | 10863 | 0.030 |
Why?
|
Methylation | 1 | 2016 | 1076 | 0.030 |
Why?
|
Reactive Oxygen Species | 1 | 2021 | 2146 | 0.030 |
Why?
|
Body Height | 1 | 2019 | 1568 | 0.030 |
Why?
|
Hypertension | 1 | 2012 | 8615 | 0.020 |
Why?
|
Metabolomics | 1 | 2021 | 1674 | 0.020 |
Why?
|
Lysine | 1 | 2016 | 988 | 0.020 |
Why?
|
Neural Conduction | 1 | 2011 | 443 | 0.020 |
Why?
|
Fatty Liver | 1 | 2016 | 807 | 0.020 |
Why?
|
Testosterone | 1 | 2019 | 2493 | 0.020 |
Why?
|
Liver | 1 | 2024 | 7574 | 0.020 |
Why?
|
Human Growth Hormone | 1 | 2013 | 648 | 0.020 |
Why?
|
Postoperative Period | 1 | 2013 | 1830 | 0.020 |
Why?
|
Japan | 1 | 2012 | 1418 | 0.020 |
Why?
|
RNA Interference | 1 | 2016 | 2836 | 0.020 |
Why?
|
Adult | 4 | 2022 | 223640 | 0.020 |
Why?
|
Immunoglobulins, Intravenous | 1 | 2011 | 669 | 0.020 |
Why?
|
Histones | 1 | 2016 | 2592 | 0.020 |
Why?
|
Prognosis | 2 | 2019 | 30022 | 0.020 |
Why?
|
Retrospective Studies | 2 | 2012 | 81801 | 0.010 |
Why?
|
Pituitary Neoplasms | 1 | 2013 | 1325 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2016 | 9562 | 0.010 |
Why?
|
Pandemics | 1 | 2022 | 8753 | 0.010 |
Why?
|
Cell Line | 1 | 2016 | 15597 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2016 | 19022 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2012 | 10776 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2016 | 9510 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 2016 | 9261 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2016 | 22355 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2012 | 20224 | 0.010 |
Why?
|
Aged | 2 | 2019 | 171562 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2013 | 39407 | 0.010 |
Why?
|
Risk Assessment | 1 | 2012 | 24318 | 0.010 |
Why?
|
Prospective Studies | 1 | 2012 | 54920 | 0.000 |
Why?
|
Young Adult | 1 | 2013 | 60049 | 0.000 |
Why?
|
Concepts
(137)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(4)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_